GENOSKIN and the CNRS have signed an agreement that offers GENOSKIN the opportunity to access, on an exclusive basis, to biosafety level 2 facilities.
The Board of Directors of the Nubbo Incubator (formerly Midi-Pyrénées Incubator) has given its approval for the support of GENOSKIN project.